Form 4: Arcutis Biotherapeutics Executive Sells Shares to Cover Tax Obligations

Masaru Matsuda, SVP General Counsel and Corporate Secretary of Arcutis Biotherapeutics, sold 5,030 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 2, 2025, Masaru Matsuda, an officer of Arcutis Biotherapeutics, Inc., sold 5,030 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on February 13, 2024.
• The shares were sold at a weighted average price of $15.1995, with individual transactions ranging from $14.75 to $15.57.
• Following the transaction, Matsuda directly owns 204,399 shares of Arcutis Biotherapeutics common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine event and doesn't necessarily indicate a change in the executive's confidence in the company.

Key Dates

Keywords

Arcutis Biotherapeutics, ARQT, Masaru Matsuda, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, RSUs